Filing Details

Accession Number:
0001209191-18-043469
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-20 16:23:40
Reporting Period:
2018-07-18
Accepted Time:
2018-07-20 16:23:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1364719 Michael Kauffman C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-18 1 $0.03 512,144 No 4 M Direct
Common Stock Acquisiton 2018-07-18 5,757 $0.26 517,901 No 4 M Direct
Common Stock Acquisiton 2018-07-18 4,242 $4.75 522,143 No 4 M Direct
Common Stock Disposition 2018-07-18 10,000 $18.27 512,143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-07-18 1 $0.00 1 $0.03
Common Stock Stock Option (right to buy) Disposition 2018-07-18 5,757 $0.00 5,757 $0.26
Common Stock Stock Option (right to buy) Disposition 2018-07-18 4,242 $0.00 4,242 $4.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-31 No 4 M Direct
0 2021-12-13 No 4 M Direct
476,061 2023-09-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 713,510 Indirect By Spouse
Common Stock 47,309 Indirect By GRAT
Common Stock 47,309 Indirect By Spouse's GRAT
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.50, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. These shares are held by the Michael G. Kauffman 2016 Qualified Annuity Interest Trust.
  4. These shares are held by the Sharon Shacham 2016 Qualified Annuity Interest Trust.
  5. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 1, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter.
  6. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on June 18, 2013, and the remaining 75% vested in 36 equal monthly installments thereafter.
  7. This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.